Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Rhoen Klinikum AG Confirms FY 2013 Guidance


Thursday, 8 Aug 2013 01:00am EDT 

Rhoen Klinikum AG announced that it continues to expect its fiscal year 2013 revenues of EUR 3.03 billion which may fluctuate within a range of plus or minus 2.5%, EBITDA is expected to reach EUR 325 million and net consolidated profit EUR 110 million. These figures may fluctuate within a range of plus or minus 5%. 

Company Quote

22.93
-0.235 -1.01%
15 Aug 2014